Mesh term Ranibizumab
Browse to parent terms:Antibodies, Monoclonal, Humanized
Description
A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.Search for this term in our Faculty Database
View this term at the NCBI website
